Insmed

+$0.06 (+0.24%) Today

$0.00 (0.00%) As of 12:00 AM UTC after-hours

Why Robinhood?

Robinhood gives you the tools you need to put your money in motion. You can buy or sell Insmed and other ETFs, options, and stocks.

About INSM

Insmed, Inc. is a biopharmaceutical company on a mission to transform the lives of patients with serious and rare diseases. Its first commercial product is ARIKAYCE (amikacin liposome inhalation suspension), which is approved in the United States for the treatment of Mycobacterium avium complex (MAC) lung disease as part of a combination antibacterial drug regimen for adult patients with limited or no alternative treatment options.

CEO

William H. Lewis

Employees

521

Headquarters

Bridgewater, New Jersey

Founded

1988

INSM Key Statistics

Market Cap

3.06B

Price-Earnings Ratio

—

Dividend Yield

—

Average Volume

849.24K

High Today

$24.84

Low Today

$24.28

Open Price

$24.36

Volume

759.74K

52 Week High

$45.44

52 Week Low

$23.28

Analyst Ratings

100%

of 9 ratings

Buy

100%

Hold

Sell

INSM Earnings

-$1.00

-$0.67

-$0.33

$0.00

Q4 FY19

Q1 FY20

Q2 FY20

Q3 FY20

Q4 FY20

Q1 FY21

Q2 FY21

Estimated

— per share

Actual

Available Aug 5, Pre-Market